Desogestrel + Testosterone Oral Contraceptive
- User: Male
- Hormonal: Hormonal
-
Delivery type:
- Oral
-
Intended Duration:
- Undetermined
- Development Stage: Phase I
- Developer(s)/researcher(s): University of Edinburgh, University of Washington
Details
- API: Desogestrel, Testosterone
- Target: Androgen Receptor
-
Mechanism of Action:
- Reduced Sperm Production
- Regimen: Undetermined
- MPT: Not Potential MPT
- Promising Attributes: Developers indicate that the API combination may achieve consistent azoospermia without negative metabolic side effects
Product Status
No Indication of Development after 2002
History
While development of a combined desogestrel and testosterone-based oral contraceptive for male users was active in the late 1990s and early 2000s through the Contraceptive Development Network, progress appears to have halted shortly after the completion of Ph I studies.